NSE:SYRMA management interview: Dabur, Piramal Pharma, M&M & KPIT: Top Managements Reveal FY27 Roadmap | Market Fatafat | ET Now
ET Now, 2026-07-30. Video: https://www.youtube.com/watch?v=SjNi8QxJXu0
- Q1 operational performance: Syrma SGS is in focus after reporting a strong first-quarter performance, starting FY27 on a very positive note.
- FY27 guidance outlook: Management expressed confidence that the company will not only meet its existing FY27 guidance, but likely outperform it.
- Performance confidence: MD Jasbir Gujral stated that the strong momentum at the start of the fiscal year provides high confidence in delivering better results than previously guided.